Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4a-0501. Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4b-0501. Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4c-0501. In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002. AMA Code Says Sep 2004 Physician-Scientists and Social Responsibility Shane K. Green, PhD A new AMA policy provide guidance for physician-scientists on dual-use research issues and reinforces the message that ethical conduct in scientific research ultimately rests with the individual researcher. Virtual Mentor. 2004;6(9):416-419. doi: 10.1001/virtualmentor.2004.6.9.code1-0409. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8
Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4a-0501.
Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4b-0501.
Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4c-0501.
In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002.
AMA Code Says Sep 2004 Physician-Scientists and Social Responsibility Shane K. Green, PhD A new AMA policy provide guidance for physician-scientists on dual-use research issues and reinforces the message that ethical conduct in scientific research ultimately rests with the individual researcher. Virtual Mentor. 2004;6(9):416-419. doi: 10.1001/virtualmentor.2004.6.9.code1-0409.